z-logo
open-access-imgOpen Access
Efficacy of Tocilizumab For Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed
Author(s) -
Bruno De Oliveira,
Jihad Mallat
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1284
Subject(s) - medicine , tocilizumab , covid-19 , pneumonia , betacoronavirus , coronavirus infections , intensive care medicine , virology , infectious disease (medical specialty) , disease , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom